Palliative chemotherapy with CMF after the same adjuvant regimen for breast cancer

Abstract

Background: The results of palliative chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in patients with advanced breast cancer who received adjuvant therapy with the same regimen were investigated. Results: Of 47 patients, 14 (30%) achieved an objective remission (median duration 9.5, range 5-21 months) and 8 (17%) stabilisation of… (More)

2 Figures and Tables

Topics

  • Presentations referencing similar topics